Edgewise Therapeutics, Inc. (EWTX)

Latest Insider Confidence Score

2026Q1

48.9
Bearish

Company insider confidence (by quarter)

2021Q1 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Novo A/S 10% Owner 6,071,703 Sep 16, 2022
Wellington Biomedical Innovation Master Investors (Cayman) I L.P. — 681,812 Mar 30, 2021
Root Jonathan D Director 455,229 Mar 31, 2021
Thompson Peter A. Director 443,792 Apr 4, 2025
Orbimed Advisors Llc Director 443,792 Apr 4, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 21, 2026 Jan 23, 2026 Edris Badreddin Director Sell 8.8 -115,471 -85.35% ✓ $3.4M
Jan 2, 2026 Jan 5, 2026 Fox Jonathan C Director Neutral 77.5 +473 2.00% ✗ -
Nov 19, 2025 Nov 24, 2025 Martin Christopher Nathan Director Neutral 52.5 - 0.00% ✗ -
Nov 24, 2025 Martin Christopher Nathan Director Neutral 52.5 - 0.00% ✗ -
Nov 12, 2025 Nov 13, 2025 Russell Alan J Chief Scientific Officer Sell 17.5 -100,000 -81.04% ✗ $2.1M
Nov 11, 2025 Nov 13, 2025 Fox Jonathan C Director Buy 95.0 +10,700 82.30% ✗ $199.4K
Nov 10, 2025 Nov 13, 2025 Nofi Michael CFO Neutral 52.5 - 0.00% ✗ -
Nov 13, 2025 Nofi Michael CFO Neutral 52.5 - 0.00% ✗ -
Oct 1, 2025 Oct 2, 2025 Fox Jonathan C Director Neutral 85.0 +728 5.93% ✗ -
Aug 26, 2025 Aug 28, 2025 Russell Alan J Chief Scientific Officer Sell 17.5 -100,000 -81.04% ✗ $1.5M
Aug 12, 2025 Aug 14, 2025 Blaustein Robert Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Aug 12, 2025 Aug 14, 2025 MOORE JOHN R General Counsel Sell 46.3 -2,098 -17.04% ✗ $28.1K
Aug 12, 2025 Aug 14, 2025 Derakhshan Behrad Chief Business Officer Sell 46.3 -2,491 -9.53% ✗ $33.4K
Aug 12, 2025 Aug 14, 2025 Carruthers R Michael CFO Sell 46.3 -1,428 -1.63% ✗ $19.1K
Aug 12, 2025 Aug 14, 2025 Russell Alan J Chief Scientific Officer Sell 46.3 -1,907 -7.54% ✗ $25.5K
Aug 12, 2025 Aug 14, 2025 KOCH KEVIN CEO Sell 42.5 -7,972 -2.11% ✗ $106.8K
Aug 12, 2025 Aug 14, 2025 Donovan Joanne M. CMO Sell 46.3 -2,862 -10.14% ✗ $38.3K
Jul 1, 2025 Jul 2, 2025 Fox Jonathan C Director Neutral 85.0 +858 7.52% ✗ -
Jun 16, 2025 Jun 18, 2025 Brege Laura Director Neutral 52.5 - 0.00% ✗ -
Jun 16, 2025 Jun 18, 2025 Edris Badreddin Director Neutral 52.5 - 0.00% ✗ -
Jun 16, 2025 Jun 18, 2025 Fox Jonathan C Director Neutral 52.5 - 0.00% ✗ -
Jun 16, 2025 Jun 18, 2025 Morris Arlene Director Neutral 52.5 - 0.00% ✗ -
Jun 16, 2025 Jun 18, 2025 ROOT JONATHAN D Director Neutral 52.5 - 0.00% ✗ -
Jun 16, 2025 Jun 18, 2025 Thompson Peter A. Director Neutral 52.5 - 0.00% ✗ -
May 1, 2025 May 7, 2025 Russell Alan J Chief Scientific Officer Sell 46.3 -1,551 -7.73% ✗ $25.5K
May 1, 2025 May 7, 2025 MOORE JOHN R General Counsel Sell 46.3 -1,930 -22.81% ✗ $31.8K
May 1, 2025 May 7, 2025 KOCH KEVIN CEO Sell 42.5 -4,276 -1.10% ✗ $70.4K
May 1, 2025 May 7, 2025 Donovan Joanne M. CMO Sell 42.5 -5,187 -19.37% ✗ $85.3K
May 1, 2025 May 7, 2025 Derakhshan Behrad Chief Business Officer Sell 46.3 -1,691 -7.67% ✗ $27.8K
May 1, 2025 May 7, 2025 Carruthers R Michael CFO Sell 46.3 -1,314 -1.60% ✗ $21.6K
Apr 3, 2025 Apr 4, 2025 Thompson Peter A. Director Buy 95.0 +496,771 3.37% ✗ $10M
Apr 3, 2025 Apr 4, 2025 ORBIMED ADVISORS LLC Director Buy 95.0 +496,771 3.37% ✗ $10M
Apr 1, 2025 Apr 3, 2025 Fox Jonathan C Director Neutral 85.0 +559 5.15% ✗ -
Mar 7, 2025 Mar 11, 2025 Russell Alan J Chief Scientific Officer Sell 50.0 -200 -1.33% ✓ $6K
Mar 7, 2025 Mar 11, 2025 KOCH KEVIN CEO Sell 58.8 -100 -0.03% ✓ $3K
Feb 5, 2025 Feb 7, 2025 Russell Alan J Chief Scientific Officer Sell 12.5 -9,215 -23.66% ✓ $276.8K
Feb 5, 2025 Feb 7, 2025 KOCH KEVIN CEO Sell 38.8 -9,536 -2.53% ✓ $287.3K
Feb 5, 2025 Feb 7, 2025 Derakhshan Behrad Chief Business Officer Sell 7.5 -10,000 -37.26% ✓ $300.3K
Jan 28, 2025 Jan 30, 2025 Donovan Joanne M. CMO Sell 7.5 -25,000 -60.45% ✓ $690.7K
Jan 21, 2025 Jan 23, 2025 Blaustein Robert Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Jan 23, 2025 Blaustein Robert Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Dec 30, 2024 Dec 31, 2024 Russell Alan J Chief Scientific Officer Sell 5.0 -100,000 -87.06% ✓ $2.7M
Dec 24, 2024 Dec 27, 2024 Semigran Marc Chief Development Officer Sell 7.5 -29,709 -81.56% ✓ $881.9K
Oct 11, 2024 Oct 16, 2024 Carruthers R Michael CFO Neutral 52.5 - 0.00% ✗ -
Sep 20, 2024 Sep 24, 2024 Russell Alan J Chief Scientific Officer Sell 17.5 -75,000 -85.50% ✗ $2.1M
Sep 20, 2024 Sep 24, 2024 MOORE JOHN R General Counsel Sell 17.5 -70,922 -91.60% ✗ $2M
Sep 20, 2024 Sep 24, 2024 Donovan Joanne M. CMO Sell 22.5 -7,162 -33.00% ✗ $202.6K
Sep 20, 2024 Sep 24, 2024 Derakhshan Behrad Chief Business Officer Sell 17.5 -42,068 -73.56% ✗ $1.2M
Sep 20, 2024 Sep 24, 2024 Carruthers R Michael CFO Sell 17.5 -125,092 -60.52% ✗ $3.6M
Aug 12, 2024 Aug 14, 2024 Semigran Marc Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Aug 12, 2024 Aug 14, 2024 Russell Alan J Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Aug 12, 2024 Aug 14, 2024 MOORE JOHN R General Counsel Neutral 52.5 - 0.00% ✗ -
Aug 12, 2024 Aug 14, 2024 Derakhshan Behrad Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Aug 12, 2024 Aug 14, 2024 KOCH KEVIN CEO Neutral 52.5 - 0.00% ✗ -
Aug 12, 2024 Aug 14, 2024 Donovan Joanne M. CMO Neutral 52.5 - 0.00% ✗ -
Aug 12, 2024 Aug 14, 2024 Carruthers R Michael CFO Neutral 52.5 - 0.00% ✗ -
Jun 10, 2024 Jun 12, 2024 Thompson Peter A. Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2024 Jun 12, 2024 Fox Jonathan C Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2024 Jun 12, 2024 Morris Arlene Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2024 Jun 12, 2024 Brege Laura Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2024 Jun 12, 2024 Edris Badreddin Director Neutral 52.5 - 0.00% ✗ -
Jun 10, 2024 Jun 12, 2024 ROOT JONATHAN D Director Neutral 52.5 - 0.00% ✗ -
May 6, 2024 May 7, 2024 Morris Arlene Director Neutral 52.5 - 0.00% ✗ -
May 7, 2024 Morris Arlene Director Neutral 52.5 - 0.00% ✗ -
May 1, 2024 May 3, 2024 MOORE JOHN R General Counsel Sell 46.3 -1,956 -37.56% ✗ $37K
May 1, 2024 May 3, 2024 Carruthers R Michael CFO Sell 46.3 -2,157 -5.77% ✗ $40.8K
May 1, 2024 May 3, 2024 Derakhshan Behrad Chief Business Officer Sell 46.3 -1,718 -11.35% ✗ $32.5K
May 1, 2024 May 3, 2024 Russell Alan J Chief Scientific Officer Sell 46.3 -1,576 -17.88% ✗ $29.8K
May 1, 2024 May 3, 2024 Donovan Joanne M. CMO Sell 42.5 -3,682 -15.62% ✗ $69.6K
May 1, 2024 May 3, 2024 KOCH KEVIN CEO Sell 45.0 -3,152 -0.88% ✗ $59.6K
Feb 7, 2024 Feb 9, 2024 MOORE JOHN R General Counsel Sell 7.5 -29,835 -100.00% ✓ $596.8K
Feb 7, 2024 Feb 9, 2024 Derakhshan Behrad Chief Business Officer Sell 10.0 -10,000 -32.20% ✓ $200.3K
Jan 23, 2024 Jan 25, 2024 Carruthers R Michael CFO Sell 5.0 -90,000 -75.62% ✓ $1.4M
Jan 23, 2024 Jan 25, 2024 Thompson Peter A. Director Buy 92.5 +454,545 3.25% ✗ $5M
Jan 23, 2024 Jan 25, 2024 ORBIMED ADVISORS LLC Director Buy 92.5 +454,545 3.25% ✗ $5M
Dec 26, 2023 Dec 28, 2023 Fox Jonathan C Director Buy 95.0 +10,857 100.00% ✗ $101K
Dec 27, 2023 Dec 28, 2023 MOORE JOHN R General Counsel Sell 10.0 -8,497 -100.00% ✓ $89.2K
Dec 26, 2023 Dec 28, 2023 Russell Alan J Chief Scientific Officer Sell 17.5 -172,585 -97.95% ✗ $1.6M
Aug 17, 2023 Aug 18, 2023 Derakhshan Behrad Chief Business Officer Neutral 52.5 - 0.00% ✗ -
Aug 17, 2023 Aug 18, 2023 MOORE JOHN R General Counsel Neutral 52.5 - 0.00% ✗ -
Aug 17, 2023 Aug 18, 2023 Carruthers R Michael CFO Neutral 52.5 - 0.00% ✗ -
Aug 17, 2023 Aug 18, 2023 Russell Alan J Chief Scientific Officer Neutral 52.5 - 0.00% ✗ -
Aug 17, 2023 Aug 18, 2023 Semigran Marc Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Aug 17, 2023 Aug 18, 2023 Donovan Joanne M. CMO Neutral 52.5 - 0.00% ✗ -
Aug 17, 2023 Aug 18, 2023 KOCH KEVIN CEO Neutral 52.5 - 0.00% ✗ -
Jun 22, 2023 Jun 26, 2023 Carruthers R Michael CFO Neutral 52.5 - 0.00% ✗ -
Jun 12, 2023 Jun 14, 2023 Fox Jonathan C Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2023 Jun 14, 2023 Thompson Peter A. Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2023 Jun 14, 2023 ROOT JONATHAN D Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2023 Jun 14, 2023 Edris Badreddin Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2023 Jun 14, 2023 Brege Laura Director Neutral 52.5 - 0.00% ✗ -
May 1, 2023 May 3, 2023 Derakhshan Behrad Chief Business Officer Sell 46.3 -1,747 -19.93% ✗ $15.6K
May 1, 2023 May 3, 2023 MOORE JOHN R General Counsel Sell 46.3 -1,897 -22.42% ✗ $16.9K
May 1, 2023 May 3, 2023 Carruthers R Michael CFO Sell 46.3 -1,336 -7.65% ✗ $11.9K
May 1, 2023 May 3, 2023 Russell Alan J Chief Scientific Officer Sell 48.8 -1,602 -0.90% ✗ $14.3K
May 1, 2023 May 3, 2023 Donovan Joanne M. CMO Sell 46.3 -3,254 -24.63% ✗ $29K
May 1, 2023 May 3, 2023 KOCH KEVIN CEO Sell 48.8 -3,203 -0.92% ✗ $28.5K
Mar 3, 2023 Mar 7, 2023 Fox Jonathan C Director Neutral 52.5 - 0.00% ✗ -
Mar 7, 2023 Fox Jonathan C Director Neutral 52.5 - 0.00% ✗ -
Dec 30, 2022 Jan 3, 2023 Semigran Marc Chief Development Officer Neutral 52.5 - 0.00% ✗ -